← Back to front page
Europe · Markets & Finance · Option Finance

Transgene présentera des données précliniques sur PoxSTG-EEV

Published by Option Finance · France 9 h ago

La société de biotechnologie française Transgene, spécialisée dans le développement d'immunothérapies reposant sur des vecteurs viraux contre le cancer, annonce la présentation…

Read the full article on Option Finance Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (tribune-assurance.optionfinance.fr)

Also worth reading

Financial Times

Euro slides to 17-month low against dollar

 This is Money

BT swoops for TalkTalk in rescue deal after fears collapse could pose national security risk

 City A.M.

Raising bank taxes will reduce jobs, former Chancellor Hunt warns Healey

 FXStreet

US Dollar Index (DXY) clings to gains near 102.30, April 2025 high amid geopolitical risks

 Reuters Markets

Euro pummelled by France's debt burden; stocks mixed

 Reuters Sustainability

Takaichi pledges fiscal discipline as Japan's debt bill rises